全文获取类型
收费全文 | 8029篇 |
免费 | 320篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 196篇 |
儿科学 | 163篇 |
妇产科学 | 281篇 |
基础医学 | 1067篇 |
口腔科学 | 63篇 |
临床医学 | 587篇 |
内科学 | 2049篇 |
皮肤病学 | 143篇 |
神经病学 | 706篇 |
特种医学 | 174篇 |
外科学 | 931篇 |
综合类 | 59篇 |
一般理论 | 1篇 |
预防医学 | 438篇 |
眼科学 | 123篇 |
药学 | 777篇 |
中国医学 | 5篇 |
肿瘤学 | 611篇 |
出版年
2023年 | 28篇 |
2022年 | 120篇 |
2021年 | 283篇 |
2020年 | 90篇 |
2019年 | 148篇 |
2018年 | 191篇 |
2017年 | 133篇 |
2016年 | 144篇 |
2015年 | 178篇 |
2014年 | 249篇 |
2013年 | 341篇 |
2012年 | 521篇 |
2011年 | 612篇 |
2010年 | 297篇 |
2009年 | 220篇 |
2008年 | 439篇 |
2007年 | 504篇 |
2006年 | 505篇 |
2005年 | 487篇 |
2004年 | 487篇 |
2003年 | 482篇 |
2002年 | 370篇 |
2001年 | 161篇 |
2000年 | 137篇 |
1999年 | 125篇 |
1998年 | 67篇 |
1997年 | 56篇 |
1996年 | 38篇 |
1995年 | 41篇 |
1994年 | 25篇 |
1993年 | 30篇 |
1992年 | 45篇 |
1991年 | 53篇 |
1990年 | 67篇 |
1989年 | 64篇 |
1988年 | 61篇 |
1987年 | 76篇 |
1986年 | 51篇 |
1985年 | 68篇 |
1984年 | 38篇 |
1983年 | 33篇 |
1982年 | 23篇 |
1981年 | 18篇 |
1980年 | 16篇 |
1979年 | 36篇 |
1977年 | 17篇 |
1974年 | 30篇 |
1973年 | 21篇 |
1972年 | 23篇 |
1971年 | 25篇 |
排序方式: 共有8374条查询结果,搜索用时 15 毫秒
1.
2.
3.
Georg Nowak 《Annals of anatomy》2006,188(3):A162
4.
5.
Proprioception is a term covering together joint position sense, kinesthesia and integration of these stimuli in the central nervous system which is needed to keep homeosthasis of joints during motion. The aim of this study is to present authors originally created measuring device working according to the principles of Barrett, aiming at evaluation of proprioception of the knee. The construction of this device is based on the Summer chair, model UPR-01B, working in connection with Bosh goniometer DWM-40L measuring angles with a precision of 0,1 degree. The device presented in this study fulfills all criteria required for this kind of apparatus and may be an alternative to other constructs produced commercially and available on the market. 相似文献
6.
7.
8.
Thromboembolic and inflammatory complications of knee joint alloplasty with cemented endoprostheses]
Edward Golec Sebastian Nowak Jaros?aw Wi?niowski Maciej Piatkowski 《Chirurgia narzadów ruchu i ortopedia polska》2004,69(5):315-319
In the presented paper the authors evaluate the long-term results of treatment for inflammatory and thromboembolic complications in knee joint alloplasty with cemented endoprostheses. The clinical material spanning the years 1998-2003 are 15 patients with analysed complications, it determine 9% of all operated. They have evaluated achieved results using the HSS knee rating scale in their own modification. As far as the authors are concerned, venographic examination is a prerequisite for appropriate care of the patients following knee joint alloplasty who might have deep venous thrombosis. It is necessary to provide similar treatment when developing infections are suspected in the perioperative period and in cases of late infections. Consequently, antibiotic therapy and a possible quick bacteriological checkup for healing a postoperative wound is a prerequisite for successful treatment. Achieved results induce statement, that thromboembolic and inflammatory complications caused at most operated chronic vein insufficiency, deficit of range of motion at operated joint and gait insufficiency. Thromboembolic complications was always related with inflammation of knee joint alloplasty in our own material. 相似文献
9.
David G Hicks Brian J Yoder Sarah Short Shannon Tarr Nichole Prescott Joseph P Crowe Andrea E Dawson G Thomas Budd Steven Sizemore Muzaffer Cicek Toni K Choueiri Raymond R Tubbs Daniel Gaile Norma Nowak Mary Ann Accavitti-Loper Andra R Frost Danny R Welch Graham Casey 《Clinical cancer research》2006,12(22):6702-6708
PURPOSE: This study aims to determine the effect of loss of breast cancer metastasis suppressor 1 (BRMS1) protein expression on disease-free survival in breast cancer patients stratified by estrogen receptor (ER), progesterone receptor (PR), or HER2 status, and to determine whether loss of BRMS1 protein expression correlated with genomic copy number changes. EXPERIMENTAL DESIGN: A tissue microarray immunohistochemical analysis was done on tumors of 238 newly diagnosed breast cancer patients who underwent surgery at the Cleveland Clinic between January 1, 1995 and December 31, 1996, and a comparison was made with 5-year clinical follow-up data. Genomic copy number changes were determined by array-based comparative genomic hybridization in 47 breast cancer cases from this population and compared with BRMS1 staining. RESULTS: BRMS1 protein expression was lost in nearly 25% of cases. Patients with tumors that were PR negative (P=0.006) or HER2 positive (P=0.039) and <50 years old at diagnosis (P=0.02) were more likely to be BRMS1 negative. No overall correlation between BRMS1 staining and disease-free survival was observed. A significant correlation, however, was seen between loss of BRMS1 protein expression and reduced disease-free survival when stratified by either loss of ER (P=0.008) or PR (P=0.029) or HER2 overexpression (P=0.026). Overall, there was poor correlation between BRMS1 protein staining and copy number status. CONCLUSIONS: These data suggest a mechanistic relationship between BRMS1 expression, hormone receptor status, and HER2 growth factor. BRMS1 staining could potentially be used in patient stratification in conjunction with other prognostic markers. Further, mechanisms other than genomic deletion account for loss of BRMS1 gene expression in breast tumors. 相似文献
10.
Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals. 总被引:5,自引:0,他引:5
Anna Gumieniczek Hanna Hopka?a Jacek Roliński Agnieszka Bojarska-Junak 《Pharmacological research》2005,52(2):162-166
Oxidative stress, defined as an imbalance between the production of reactive oxygen species (ROS) and antioxidant defense, is considered to be an important pathogenic factor in diabetes mellitus and its complications. In diabetic state, ROS might also be implicated in promoting a state of systemic inflammation. Recently, it was demonstrated that antioxidant therapy could be used to stop the initiation and propagation of this inflammatory response. Repaglinide is a new oral antidiabetic agent with a possible antioxidant activity. Therefore, in the present study, a possible therapeutic value of repaglinide in ameliorating the oxidative and inflammatory processes was tested in diabetic animals. In the study, the levels of total antioxidant status (TAS), ascorbic acid (AA), protein carbonyl groups (PCG) and interleukin-6 (IL-6) were determined in plasma of diabetic rabbits after 4 and 8 weeks of repaglinide treatment (1mg daily). Ex vivo analysis revealed that there were significant differences in these markers between hyperglycemic and control animals (P<0.05). Some of these parameters were ameliorated by repaglinide treatment. In diabetic rabbits treated with repaglinide, protein oxidation was diminished by 17.8% after 8 weeks of experiment. The level of AA in plasma of diabetic treated animals was higher than in non-treated diabetic groups (by 9.4 and 22.6% after 4 and 8 weeks, respectively). In diabetic treated animals, the TAS level was also significantly increased (by 23.6 and 16.7%). However, in diabetic rabbits, repaglinide did not affect the concentration of IL-6. 相似文献